Table 5 Antimicrobial activity of antimicrobial agents against Streptococcus spp. collected globally between 2004 - 2013

Streptococcus agalactiae (n = 12,819)

AMC

0.12

≤0.03 – ≥ 16

-

-

AMP

0.12

≤0.06 – 0.25

100

-

CRO

0.12

≤0.03 – 0.5

100

-

IPM (n = 2,511)

0.25

≤0.12 – 8

-

-

LVX

1

≤0.06 – ≥ 64

98.6

1.1

LIN

1

≤0.5 – 2

100

-

MEM (n = 10,308)

≤0.12

≤0.12 – 1

99.9

-

MIN

≥16

≤0.25 – ≥ 16

20.6

70.6

PEN

0.12

≤0.06 – 0.12

100

-

TZP

0.5

≤0.25 – ≥ 32

-

-

TGC

0.12

≤0.008 – 2

99.9

-

VAN

0.5

≤0.12 – 1

100

-

AMC

2

≤0.03 – ≥ 16

92.8

3.5

AMP

4

≤0.06 – ≥ 32

-

-

AZM (n = 12,973)

64

≤0.03 – ≥ 128

67.2

32.4

CRO

1

≤0.03 – ≥ 128

95.0

1.2

CLR (n = 12,973)

64

≤0.015 – ≥ 128

67.5

32.0

CLI (n = 12,973)

≥128

≤0.015 – ≥ 128

80.8

18.9

ERY (n = 12,973)

64

≤0.015 – ≥ 128

66.8

32.7

IPM (n = 3,154)

0.5

≤0.12 – ≥ 32

74.2

4.1

LVX

1

≤0.06 – ≥ 64

98.9

0.7

LIN

1

≤0.5 – 4

99.9

-

MEM (n = 11,408)

0.5

≤0.12 – ≥ 32

81.4

10.0

MIN

8

≤0.25 – ≥ 16

64.4

26.9

PEN

2

≤0.06 – ≥ 16

61.9

14.8

TZP

2

≤0.25 – ≥ 32

-

-

TGC

0.06

≤0.008 – 0.25

99.9

-

VAN

0.5

≤0.12 – 1

100

-

AMC

8

≤0.03 – ≥ 16

53.2

22.7

AZM (n = 1,971)

≥128

≤0.03 – ≥ 128

21.5

78.0

CRO

2

0.06 – ≥ 128

69.9

7.2

CLR (n = 1,971)

≥128

≤0.015 – ≥ 128

21.8

77.8

CLI (n = 1,971)

≥128

≤0.015 – ≥ 128

43.2

56.1

ERY (n = 1,971)

≥128

≤0.015 – ≥ 128

20.9

78.7

IPM (n = 357)

1

≤0.12– ≥ 32

1.4

29.7

LVX

1

≤0.06 – ≥ 64

97.5

1.9

LIN

1

≤0.5 – 2

100

-

MEM (n = 1,795)

1

≤0.12 – ≥ 32

6.1

58.4

MIN

≥16

≤0.25 – ≥ 16

27.6

60.3

TZP

8

≤0.25 – ≥ 32

-

-

TGC

0.03

≤0.008 – 0.12

99.8

-

VAN

0.5

≤0.12 – 1

100

-